MedPath

Invloed van ultrafijn stof op de gezondheid van gezonde vrijwilligers:Klinische studie ultrafijn stof rondom Schiphol

Conditions
ung functionHeart functionInflammationOxidative stress
Registration Number
NL-OMON27988
Lead Sponsor
Academic Medical Center Amsterdam in collaboration with the National Institute for Public Health and the Environment (RIVM)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

•Healthy subjects between 18 and 35 years of age

•No clinically significant findings during physical examination

Exclusion Criteria

•History of pulmonary or cardiovascular events/diseases

•History of hay fever

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary endpoints are exhaled Nitric Oxide (FeNO) for inflammation and blood pressure for the cardiovascular effects
Secondary Outcome Measures
NameTimeMethod
Secondary outcome parameters are:<br /><br>-Lung function (Flow/Volume)<br /><br>-Oxygen saturation<br /><br>-Heart rate<br /><br>-ECG<br /><br>-SpiroNose measurement<br /><br>-Oxidative stress markers in urine collected shortly before and 24 hours after on site exposure<br /><br>-Molecular markers as measured in peripheral blood<br>
© Copyright 2025. All Rights Reserved by MedPath